Lexicon Pharmaceuticals LXRX Stock
Lexicon Pharmaceuticals Price Chart
Lexicon Pharmaceuticals LXRX Financial and Trading Overview
| Lexicon Pharmaceuticals stock price | 0.71 USD |
| Previous Close | 2.5 USD |
| Open | 2.51 USD |
| Bid | 0 USD x 3000 |
| Ask | 0 USD x 3000 |
| Day's Range | 2.45 - 2.58 USD |
| 52 Week Range | 1.4 - 3.79 USD |
| Volume | 2.11M USD |
| Avg. Volume | 1.9M USD |
| Market Cap | 629.26M USD |
| Beta (5Y Monthly) | 1.284859 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.63 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7 USD |
LXRX Valuation Measures
| Enterprise Value | 423.56M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.5869565 |
| PEG Ratio (5 yr expected) | -0.07 |
| Price/Sales (ttm) | 4994.1626 |
| Price/Book (mrq) | 5.538793 |
| Enterprise Value/Revenue | 3361.568 |
| Enterprise Value/EBITDA | -3.918 |
Trading Information
Lexicon Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.284859 |
| 52-Week Change | 76.02% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.79 USD |
| 52 Week Low | 1.4 USD |
| 50-Day Moving Average | 2.74 USD |
| 200-Day Moving Average | 2.39 USD |
LXRX Share Statistics
| Avg. Volume (3 month) | 1.9M USD |
| Avg. Daily Volume (10-Days) | 3.86M USD |
| Shares Outstanding | 244.85M |
| Float | 82.65M |
| Short Ratio | 4.51 |
| % Held by Insiders | 1.16% |
| % Held by Institutions | 81.32% |
| Shares Short | 10.76M |
| Short % of Float | 11.64% |
| Short % of Shares Outstanding | 5.67% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -86128.57% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.38% |
| Return on Equity (ttm) | -122.16% |
Income Statement
| Revenue (ttm) | 126K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | -35.099% |
| Gross Profit (ttm) | -52677000 USD |
| EBITDA | -108092000 USD |
| Net Income Avi to Common (ttm) | -110402000 USD |
| Diluted EPS (ttm) | -0.59 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 105.94M USD |
| Total Cash Per Share (mrq) | 0.56 USD |
| Total Debt (mrq) | 55.59M USD |
| Total Debt/Equity (mrq) | 63.14 USD |
| Current Ratio (mrq) | 5.378 |
| Book Value Per Share (mrq) | 0.464 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -97043000 USD |
| Levered Free Cash Flow (ttm) | -59122124 USD |
Profile of Lexicon Pharmaceuticals
| Country | United States |
| State | TX |
| City | The Woodlands |
| Address | 2445 Technology Forest Boulevard |
| ZIP | 77381 |
| Phone | 281 863 3000 |
| Website | https://www.lexpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 135 |
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
Q&A For Lexicon Pharmaceuticals Stock
What is a current LXRX stock price?
Lexicon Pharmaceuticals LXRX stock price today per share is 0.71 USD.
How to purchase Lexicon Pharmaceuticals stock?
You can buy LXRX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lexicon Pharmaceuticals?
The stock symbol or ticker of Lexicon Pharmaceuticals is LXRX.
Which industry does the Lexicon Pharmaceuticals company belong to?
The Lexicon Pharmaceuticals industry is Biotechnology.
How many shares does Lexicon Pharmaceuticals have in circulation?
The max supply of Lexicon Pharmaceuticals shares is 363.18M.
What is Lexicon Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Lexicon Pharmaceuticals PE Ratio is now.
What was Lexicon Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Lexicon Pharmaceuticals EPS is -0.63 USD over the trailing 12 months.
Which sector does the Lexicon Pharmaceuticals company belong to?
The Lexicon Pharmaceuticals sector is Healthcare.
Lexicon Pharmaceuticals LXRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4148.65 USD — |
+0.54
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4470.08 USD — |
-1.41
|
— — | 4446.23 USD — | 4506.67 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8504.39 USD — |
+1.34
|
— — | 8367.19 USD — | 8515.13 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4131.38 USD — |
-1.41
|
— — | 4109.33 USD — | 4165.2 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 21278.67 USD — |
+1.26
|
— — | 20945.45 USD — | 21305.05 USD — | — - | — — |
- {{ link.label }} {{link}}